Contribution of the serine kinase c-Jun N-terminal kinase (JNK) to oxidant-induced insulin resistance in isolated rat skeletal muscle

Archives of Physiology and Biochemistry

Volumn 118, Issue 5, 2012, Pages 231-236

  Santos, Fernando R ^a   Diamond Stanic, Maggie K ^a   Prasannarong, Mujalin ^a,b   Henriksen, Erik J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Mahidol University ^*  (Thailand)

Author keywords

Akt serine phosphorylation; Glucose transport; Hydrogen peroxide; Soleus muscle; SP600125

Indexed keywords

ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; GLUCOSE; HYDROGEN PEROXIDE; ISOENZYME; OXIDIZING AGENT; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL; ARTICLE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; IN VITRO STUDY; INSULIN RESISTANCE; METABOLISM; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL; ZUCKER RAT;

ANIMALS; ANTHRACENES; BIOLOGICAL TRANSPORT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; GLUCOSE; HYDROGEN PEROXIDE; INSULIN RESISTANCE; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SKELETAL; OXIDANTS; OXIDATIVE STRESS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, ZUCKER; SIGNAL TRANSDUCTION;

MAMMALIA; RATTUS;

EID: 84869420795     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.713366     Document Type: Article

References (27)

1. Abdul-Ghani MA, DeFronzo RA. (2010). Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010: Article ID 476279, 19 pages; doi:10.1155/2010/476279.
2. Archuleta TL, Lemieux AM, Saengsirisuwan V, Teachey MK, Lindborg KA, Kim JS, Henriksen EJ. (2009). Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK. Free Radic Biol Med 47:1486-93.
3. Bennett BL, Sasaki DT, Murray BW, et al. (2001). SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci 98:13681-6.
4. Blair AS, Hajduch E, Litherland GJ, Hundal HS. (1999) Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress: Evidence for cross talk between the insulin and SAPK2/p38 mitogen activated-protein kinase signaling pathways. J Biol Chem 274:36293-9.
5. Cirialdi T P, Nikoulina SE, Bandukwalam RA, Carter L, Henry RR. (2007). Role of glycogen synthase kinase-3a in insulin action in cultured human muscle cells. Endocrinology 148:4393-9.
6. Davies KJ. (1995). Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61:1-31.
7. DeFronzo RA, Ferrannini E. (1991). Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-94.
8. DeFronzo RA. (1997). Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diab Rev 5:177-269.
9. DeFronzo RA. (2004). Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787-835.
10. DeFronzo RA. (2009). From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773-95.
11. Diamond-Stanic MK, Marchionne EM, Teachey MK, Durazo DE, Kim JS, Henriksen EJ. (2011). Critical role of transient p38 MAPK activation in skeletal muscle insulin resistance caused by low-level in vitro oxidant stress. Biochem Biophys Res Commun, 405:439-444.
12. Dokken BB, Henriksen EJ. (2006). Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in pre-diabetic obese Zucker rats. Am J Physiol Endocrinol Metab 291:E207-13.
13. Dokken BB, Sloniger JA, Henriksen EJ. (2005). Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab 288:E1188-94.
14. Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, Henriksen EJ. (2008). Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab 294:E615-21.
15. Evans JL, Goldfne ID, Maddux BA, Grodsky GM. (2002). Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrin Rev 23:599-622.
16. Hansen PA, Gulve EA, Holloszy JO. (1994). Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76:979-85.
17. Henriksen EJ, Jacob S. (1995). Efects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 44:267-72.
18. Henriksen EJ. (2010). Dysregulation of glycogen synthase kinase-3 and the etiology of insulin resistance and type 2 diabetes. Curr Diab Rev 6:285-93.
19. Henriksen EJ, Diamond-Stanic MK, Marchionne EM. (2011). Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 51:993-9.
20. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420:333-6.
21. Holloszy JO, Hansen PA. (1996). Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 128:99-193.
22. Kim JS, Saengsirisuwan V, Sloniger JA, Teachey MK, Henriksen EJ. (2006). Stimulation of muscle glucose transport by an oxidant stress: roles of insulin signaling and p38 MAP kinase. Free Radic Biol Med 41:818-24.
23. Li Y-P, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. (2005). TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19:362-70.
24. Nikoulina SE, Cirialdi TP, Mudaliar S, Carter L, Johnson K, Henry RR. (2002). Inhibition of glycogen synthase kinase-3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51:2190-98.
25. Sies H. (1997). Oxidative stress: Oxidants and antioxidants. Exp Physiol 82:291-5.
26. Solinas G, Karin M. (2010). JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction. FASEB J 24:2596-611.
27. Zierath JR, Krook A, Wallberg-Henriksson H. (2000). Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43:821-35.